Cost-effectiveness of a fixed combination of netupitant and palonosetron (NEPA) relative to aprepitant plus granisetron (APR + GRAN) for prophylaxis of chemotherapy-induced nausea and vomiting (CINV): a trial-based analysis - Botteman, Marc; Nickel, Katharina; Corman, Shelby; Turini, Marco; Binder, Gary (Supportive care in cancer, 2020)
Keywords: Antiemetics; Antiemetics - pharmacology; Antiemetics - therapeutic use; Aprepitant - pharmacology; Aprepitant - therapeutic use; Chemotherapy; Cost analysis; Cost reduction; Cost-Benefit Analysis - methods; Drug Therapy, Combination - economics; Drug Therapy, Combination - methods; Economic analysis; Female; Granisetron - pharmacology; Granisetron - therapeutic use; Humans; Male; Medicine; Medicine & Public Health; Middle Aged; Nausea; Nausea - chemically induced; Nausea - drug therapy; Nursing; Nursing Research; Oncology; Original; Original Article; Pain Medicine; Palonosetron - pharmacology; Palonosetron - therapeutic use; Pyridines - pharmacology; Pyridines - therapeutic use; Rehabilitation Medicine; Vomiting - chemically induced; Vomiting - drug therapy; United States--US; CINV; Chemotherapy; Nausea; Cost-effectiveness; Netupitant and palonosetron; Antiemetic